Linden Thomas Advisory Services, LLC Novo Nordisk A S Transaction History

Linden Thomas Advisory Services, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 30, 2025	BUY	$69.3 - $90.95 $31,600 - $41,473	456 Added 12.83%	4,011 $279 Million
Q4 2024 Jan 21, 2025	BUY	$85.0 - $120.04 $61,710 - $87,149	726 Added 25.66%	3,555 $306 Million
Q3 2024 Oct 17, 2024	BUY	$119.07 - $145.42 $67,393 - $82,307	566 Added 25.01%	2,829 $337 Million
Q2 2024 Jul 10, 2024	BUY	$122.71 - $146.91 $44,175 - $52,887	360 Added 18.92%	2,263 $323 Million
Q1 2024 Apr 29, 2024	SELL	$102.11 - $135.92 $16,950 - $22,562	-166 Reduced 8.02%	1,903 $244 Million

Q4 2023 Feb 01, 2024	BUY	$87.78 - $105.45 $181,616 - $218,176	2,069 New	2,069 $214 Million

1,686

303M

25.9M

43.8M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $109B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Linden Thomas Advisory Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Linden Thomas Advisory Services, LLC with notifications on news.